Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer

By Heys Steven   Stewart Keith   McKenzie Emma   Miller Iain   Wong Simon   Sellar Grant   Rees Andrew  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 539-548

Springer Publishing Company

Access to resources Recommend Favorite

Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer

By Peters-Engl Christian   Cassik Pia   Schmidt Irene   Denison Ursula   Medl Michael   Pokieser Wolfgang   Sevelda Paul  

Acta Oncologica, Vol. 44, Iss. 2, 2005-03 ,pp. : 129-133

Informa Healthcare

Access to resources Recommend Favorite

Impact of adjuvant chemotherapy delay on survival in cancer breast patients

By Ghany Dalia  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 1, 2013-01 ,pp. : 20-24

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel: response in patients who have received at least two prior chemotherapy regimes for metastatic breast cancer

By Archer C.D.   Lowdell C.   Sinnett H.D.   English J.   Khan S.   Coombes R.C.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 816-819

Elsevier

Access to resources Recommend Favorite

Prediction of response to primary chemotherapy for operable breast cancer

By Colleoni M.   Orvieto E.   Nole   Orlando L.   Minchella I.   Viale G.   Peruzzotti G.   Robertson C.   Noberasco C.   Galimberti V.   Sacchini V.   Veronesi P.   Zurrida S.   Orecchia R.   Goldhirsch A.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 574-579

Elsevier

Access to resources Recommend Favorite